GLIMDA-MV 1

Description

Glimda-MV 1 Tablet is a fixed-dose combination anti-diabetic medicine from Cipla Ltd, containing Metformin Hydrochloride 500mg, Glimepiride 1mg, and Voglibose 0.2mg per tablet. It is specially formulated for the management of type 2 diabetes mellitus in adults, especially when lifestyle changes or single-drug therapy does not provide adequate blood sugar control.

How it Works:

• Metformin lowers blood sugar by reducing glucose production in the liver, enhancing the body’s response to insulin, and decreasing glucose absorption from the intestines.

• Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin, aiding glucose uptake by cells.

• Voglibose is an alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates in the intestines, thereby preventing sharp increases in blood glucose after meals (postprandial spikes).

The combination of these three medicines targets different mechanisms in diabetes, resulting in more robust and sustained glycemic control and lowering the risk of complications such as nerve damage, kidney problems, and heart disease.

Uses of Glimda-MV 1:

• Management of type 2 diabetes mellitus

• Control of fasting and postprandial blood glucose

• Prevention of long-term diabetes complications in adults

Key Benefits:

• Provides effective, multi-faceted blood sugar control

• Reduces the need for multiple separate diabetes pills

• Prevents sharp rises in blood sugar after meals

• Decreases risk of diabetes-related complications

• May help with weight management in some patients

Dosage & Administration:

• Usual dosage: One tablet daily (frequency and timing as directed by doctor), with meals to minimize gastrointestinal side effects

• Swallow whole with water; do not crush or chew

• Follow diet and exercise recommendations strictly for best results

• Take at the same time each day for consistent effectiveness

Safety & Precautions:

• Use only under medical guidance

• Patients with kidney or liver disease, elderly, or with a history of low blood sugar, should use with caution

• Common side effects: hypoglycemia (if meals are missed or delayed), nausea, stomach pain, diarrhea, dizziness, headache

• Take with meals to reduce gastrointestinal upset

• Monitor blood sugar regularly during treatment

• Not for use in type 1 diabetes, diabetic ketoacidosis, or severe renal/hepatic impairment

• Avoid alcohol during therapy as it increases the risk of side effects

Note:
Do not stop or change the dose on your own. Always carry a sugar source for hypoglycemia, and inform your healthcare provider about all other medicines you use.